Increased Alu RNA processing in Alzheimer brains is linked to gene expression changes

Area of Science:

• Molecular Biology
• Neuroscience
• Genetics

Background:

• Alzheimer's disease (AD) pathogenesis involves unknown molecular processes.
• Non-coding RNAs from small interspersed nuclear elements (SINEs), like Alu repeats in humans, regulate gene expression.
• These SINE RNAs can suppress transcription and have self-cleaving activity.

Purpose of the Study:

• To investigate the role and processing of human Alu RNAs in Alzheimer's disease.
• To determine if Alu RNA processing patterns in human AD brains mirror those observed in mouse models.
• To explore the relationship between Alu RNA levels, processing, and gene expression changes in AD.

Main Methods:

• Analysis of Alu RNA processing rates in post-mortem human brain tissue from AD patients and controls.
• Correlation analysis between Alu RNA levels/processing and gene expression profiles in AD brains.
• In vitro assays to assess the effect of proteins, such as HSF1, on Alu RNA processing.

Main Results:

• Human Alu RNAs are processed, and this processing rate is significantly increased in the brains of AD patients.
• Increased Alu RNA processing correlates with the upregulation of specific genes in AD.
• Higher levels of intact Alu RNA correlate with the downregulation of other genes in AD.
• In vitro experiments demonstrate that HSF1 accelerates Alu RNA processing.

Conclusions:

• The processing and expression of SINE-derived RNAs, specifically Alu RNAs, are deregulated in the human brain during Alzheimer's disease.
• These findings suggest a conserved mechanism of SINE RNA deregulation in AD pathogenesis across species.
• Alu RNA processing dynamics may play a significant role in modulating gene expression during amyloid beta pathology.